LisaAnnBeckMD
Dermatology • Rochester, NYProfessor, Dermatology, Medicine and Pathology, University of Rochester School of Medicine & Dentistry
Dr. Beck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Crittenden Blvd
Rochester, NY 14642Phone+1 585-275-7546Fax+1 585-461-3509
Education & Training
Johns Hopkins UniversityPost-Doctoral Fellowship, Allergy and Immunology, 1992 - 1994
Duke University HospitalResidency, Dermatology, 1987 - 1990
University of RochesterResidency, Internal Medicine, 1985 - 1987
Stony Brook University Health Sciences Center School of MedicineClass of 1985
Certifications & Licensure
NY State Medical License 2006 - 2025
MD State Medical License 1990 - 2006
NC State Medical License 1987 - 1992- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis Start of enrollment: 2008 Aug 01
- Registry for the Atopic Dermatitis Research Network Start of enrollment: 2011 Aug 01
- Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients Start of enrollment: 2013 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 315 citationsNeuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegiaMegan L. Gill, Peter J. Grahn, Jonathan S. Calvert, Margaux B. Linde, Igor Lavrov
Nature Medicine. 2018-09-24 - 46 citationsGenetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum.Pei Song Gao, Donald Y.M. Leung, Nicholas Rafaels, Mark Boguniewicz, T. Hand
The Journal of Investigative Dermatology. 2012-03-01 - 90 citationsLaboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).A. Wollenberg, Lisa A. Beck, Andrew Blauvelt, Eric L. Simpson, Zhen Chen
The British Journal of Dermatology. 2020-05-01
Journal Articles
- Image Gallery: Hairy‐Cell Leukaemia Presenting with Sweet SyndromeG Scott, L A Beck, The British Journal of Dermatology
Press Mentions
Every-Other-Week Dose of Dupilumab Safe, Effective over Long TermMay 12th, 2022- DermTech Announces New Scientific Advisory Board MembersFebruary 8th, 2021
Research Finds Needleless Flu Vaccine Patch to Be EffectiveSeptember 19th, 2019- Join now to see all
Grant Support
- Mechanisms Of Chemokine-Induced Inflammation In HumansNational Institute Of Allergy And Infectious Diseases2001–2005
- Steroid Mechanisms In Cutaneous Allergic InflammationNational Institute Of Allergy And Infectious Diseases1994–1998
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
